Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Alonso

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Plos One|August 30, 2018
A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumoursLisa Redford, Ghanim Alhilal, Stephanie Needham, et al.
Brain Stimulation|November 11, 2017
Limited output transcranial electrical stimulation (LOTES-2017): Engineering principles, regulatory statutes, and industry standards for wellness, over-the-counter, or prescription devices with low riskMarom Bikson, Bhaskar Paneri, Andoni Mourdoukoutas, et al.
Journal of Psychiatric Research|August 30, 2022
The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosisMaría García-López, Miguel Alonso-Sánchez, Itziar Leal, et al.
Cell Death Discovery|January 3, 2024
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancerSandra P Nunes, Lucia Morales, Carolina Rubio, et al.
Scientific Reports|March 12, 2026
CD44v6 is associated with tumor aggressiveness and chemoresistance in bladder cancerIris Lodewijk, Carolina Rubio, Pontus Eriksson, et al.
Advanced Therapeutics|October 10, 2022
Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating NeuropathiesJohn W Rumsey, Case Lorance, Max Jackson, et al.
Clinical and Translational Science|June 1, 2022
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patientsMaurits F J M Vissers, Jules A A C Heuberger, Geert Jan Groeneveld, et al.
Cancers|January 21, 2022
Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder CancerCarolina Rubio, José Avendaño-Ortiz, Raquel Ruiz-Palomares, et al.
Plos Biology|March 15, 2018
Taxonomy based on science is necessary for global conservationScott A Thomson, Richard L Pyle, Shane T Ahyong, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Plos One|August 30, 2018
A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumoursLisa Redford, Ghanim Alhilal, Stephanie Needham, et al.
Brain Stimulation|November 11, 2017
Limited output transcranial electrical stimulation (LOTES-2017): Engineering principles, regulatory statutes, and industry standards for wellness, over-the-counter, or prescription devices with low riskMarom Bikson, Bhaskar Paneri, Andoni Mourdoukoutas, et al.
Journal of Psychiatric Research|August 30, 2022
The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosisMaría García-López, Miguel Alonso-Sánchez, Itziar Leal, et al.
Cell Death Discovery|January 3, 2024
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancerSandra P Nunes, Lucia Morales, Carolina Rubio, et al.
Scientific Reports|March 12, 2026
CD44v6 is associated with tumor aggressiveness and chemoresistance in bladder cancerIris Lodewijk, Carolina Rubio, Pontus Eriksson, et al.
Advanced Therapeutics|October 10, 2022
Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating NeuropathiesJohn W Rumsey, Case Lorance, Max Jackson, et al.
Clinical and Translational Science|June 1, 2022
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patientsMaurits F J M Vissers, Jules A A C Heuberger, Geert Jan Groeneveld, et al.
Cancers|January 21, 2022
Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder CancerCarolina Rubio, José Avendaño-Ortiz, Raquel Ruiz-Palomares, et al.
Plos Biology|March 15, 2018
Taxonomy based on science is necessary for global conservationScott A Thomson, Richard L Pyle, Shane T Ahyong, et al.
Pageof 15